Author Question: Define self-monitoring. Would someone high or low on self-monitoring be more likely to act ... (Read 90 times)

HCHenry

  • Hero Member
  • *****
  • Posts: 591
Define self-monitoring. Would someone high or low on self-monitoring be more likely to act differently across situations? Why?
 
  What will be an ideal response?

Question 2

Define the spotlight effect and provide an example of how it works.
 
  What will be an ideal response?



yotaSR5

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

Answer: Self-monitoring: the tendency to be chronically concerned with one's public image and to adjust one's actions to fit the needs of the current situation. People who are high on self-monitoring act more inconsistently because they adjust their self-presentation to fit the situation.

Answer to Question 2

Answer: The tendency for people to think that others are paying much closer attention to them than they really are.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library